International research indicates giving infants nirsevimab would cause sharp drop in rates of respiratory syncytial virus infection
A vaccine could reduce by 80% the numbers of babies and young children admitted to hospital with respiratory syncytial virus (RSV), a “groundbreaking” study has found.
The study, published in the peer-reviewed New England Journal of Medicine, involved 8,058 healthy babies aged up to 12 months from the UK, France and Germany, who were approaching their first RSV season.
About Author
More Stories
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton
Bizarre Australian mole even more unusual than first thought, new research reveals
Male mosquitoes to be genetically engineered to poison females with semen in Australian research